Education
About Us
Working with TipRanks
Follow Us
Telo Genomics Corp (TSE:TELO)
:TELO
RESEARCH TOOLSreports
Total Valuation
Telo Genomics Corp has a market cap or net worth of C$9.48M. The enterprise value is ―.
Market CapC$9.48M
Enterprise Value―
Share Statistics
Telo Genomics Corp has 99,811,180 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding99,811,180
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Telo Genomics Corp’s return on equity (ROE) is -4.60 and return on invested capital (ROIC) is -462.40%.
Return on Equity (ROE)-4.60
Return on Assets (ROA)-2.81
Return on Invested Capital (ROIC)-462.40%
Return on Capital Employed (ROCE)-4.61
Revenue Per Employee0.00
Profits Per Employee-339.13K
Employee Count8
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Telo Genomics Corp is -4.87. Telo Genomics Corp’s PEG ratio is 0.26.
PE Ratio-4.87
PS Ratio―
PB Ratio22.38
Price to Fair Value22.38
Price to FCF-5.36
Price to Operating Cash Flow-5.37
PEG Ratio0.26
Income Statement
In the last 12 months, Telo Genomics Corp had revenue of 0.00 and earned -2.71M in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit-39.54K
Operating Income-2.72M
Pretax Income-2.71M
Net Income-2.71M
EBITDA-2.67M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -1.96M and capital expenditures -2.31K, giving a free cash flow of -1.96M billion.
Operating Cash Flow-1.96M
Free Cash Flow-1.96M
Free Cash Flow per Share-0.02
Dividends & Yields
Telo Genomics Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change-50.00%
50-Day Moving Average0.11
200-Day Moving Average0.14
Relative Strength Index (RSI)45.01
Average Volume (3m)19.90K
Important Dates
Telo Genomics Corp upcoming earnings date is Jun 3, 2025, TBA Not Confirmed.
Last Earnings DateFeb 26, 2025
Next Earnings DateJun 3, 2025
Ex-Dividend Date―
Financial Position
Telo Genomics Corp as a current ratio of 2.45, with Debt / Equity ratio of 0.00%
Current Ratio2.45
Quick Ratio2.45
Debt to Market Cap0.00
Net Debt to EBITDA0.30
Interest Coverage Ratio-589.16
Taxes
In the past 12 months, Telo Genomics Corp has paid 10.00K in taxes.
Income Tax10.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Telo Genomics Corp EV to EBITDA ratio is -4.65, with an EV/FCF ratio of -5.04.
EV to Sales0.00
EV to EBITDA-4.65
EV to Free Cash Flow-5.04
EV to Operating Cash Flow-5.05
Balance Sheet
Telo Genomics Corp has C$2.25M in cash and marketable securities with C$0.00 in debt, giving a net cash position of -C$2.25M billion.
Cash & Marketable SecuritiesC$2.25M
Total DebtC$0.00
Net Cash-C$2.25M
Net Cash Per Share-C$0.02
Tangible Book Value Per Share<C$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Telo Genomics Corp is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast28.89%